At a glance
- Originator Abbott Laboratories
- Class Anti-ischaemics; Antihypertensives
- Mechanism of Action Endothelin A receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cerebral ischaemia; Coronary artery restenosis; Heart failure; Hypertension